Literature DB >> 28236052

Spontaneous subdural hematomas particularly with a decreased coagulation factor XIII activity require follow-ups of the neuroradiological diagnostic.

Bert Bosche1,2, Bastian Kraus3, Marek Molcanyi4,5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28236052     DOI: 10.1007/s00234-017-1793-3

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


× No keyword cloud information.
  5 in total

1.  Massive spontaneous parasellar and retroclival subdural hematoma.

Authors:  Zongli Han; Yanli Du; Hui Qi; Wei Yin
Journal:  Neuroradiology       Date:  2015-12-21       Impact factor: 2.804

2.  Safety of Factor XIII Concentrate: Analysis of More than 20 Years of Pharmacovigilance Data.

Authors:  Cristina Solomon; Wolfgang Korte; Dietmar Fries; Inna Pendrak; Christine Joch; Albrecht Gröner; Ingvild Birschmann
Journal:  Transfus Med Hemother       Date:  2016-08-03       Impact factor: 3.747

3.  Occurrence and recurrence of spontaneous chronic subdural haematoma is associated with a factor XIII deficiency.

Authors:  Bert Bosche; Marek Molcanyi; Thomas Noll; Matthias Kochanek; Bastian Kraus; Bernhard Rieger; Faycal El Majdoub; Christian Dohmen; Mario Löhr; Roland Goldbrunner; Gerrit Brinker
Journal:  Clin Neurol Neurosurg       Date:  2012-04-26       Impact factor: 1.876

4.  Spontaneous retroclival hematoma: a case series.

Authors:  Jared Narvid; Matthew R Amans; Daniel L Cooke; Steven W Hetts; William P Dillon; Randall T Higashida; Christopher F Dowd; Van V Halbach
Journal:  J Neurosurg       Date:  2015-08-07       Impact factor: 5.115

5.  Glycaemic control improves fibrin network characteristics in type 2 diabetes - a purified fibrinogen model.

Authors:  Marlien Pieters; Namukolo Covic; Francois H van der Westhuizen; Chandrasekaran Nagaswami; Yelena Baras; Du Toit Loots; Johann C Jerling; Dale Elgar; Kathryn S Edmondson; Danie G van Zyl; Paul Rheeder; John W Weisel
Journal:  Thromb Haemost       Date:  2008-04       Impact factor: 5.249

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.